Inotropic drugs for the treatment of heart failure.
Mancini
D M
DM
Keren
G
G
Aogaichi
K
K
LeJemtel
T H
TH
Sonnenblick
E H
EH
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D002118:Calcium / Q000494:pharmacology; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D002395:Catecholamines / Q000494:pharmacology; D005934:Glucagon / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006632:Histamine / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D009200:Myocardial Contraction / Q000187:drug effects; D012039:Regional Blood Flow / Q000187:drug effects; D014970:Xanthines / Q000627:therapeutic use
D000316:Adrenergic alpha-Agonists; D002316:Cardiotonic Agents; D002395:Catecholamines; D014970:Xanthines; D006632:Histamine; D005934:Glucagon; D002118:Calcium